-
Drug-Eluting Beads Bronchial Arterial Chemoembolization Combined with Immunotherapy Resulted in Pathological Complete Response of Squamous Cell Lung Cancer: A Case Report
18 Dec 2024 16:06 GMT
… include doxorubicin, pirarubicin, irinotecan, oxaliplatin, cisplatin, gemcitabine … drug for treating lung cancer. Importantly, epirubicin … arterial chemoembolization in lung cancer patients with hemoptysis … assessment of lung cancer resection specimens …
-
New Therapies Expand Options in Recurrent Small Cell Lung Cancer
14 Nov 2024 00:03 GMT
… to managing recurrent small cell lung cancer (SCLC), especially in patients who … we had were topotecan and irinotecan, but as of May of …
-
New therapies lurbinectedin and tarlatamab bring hope for small cell lung cancer treatment
07 Nov 2024 05:16 GMT
… small cell lung cancer (SCLC), one of the least curable lung cancers, is about … carboplatin arm.
“In small cell lung cancer, atezolizumab showed efficacy independent of … drugs, including topotecan, belotecan, and irinotecan.
“The side effects of lurbinectedin …
-
Current Status and Future Prospects of TROP-2 ADCs in Lung Cancer Treatment
05 Nov 2024 16:00 GMT
… Characteristics of Patients with Lung Cancer
Lung cancer is a complex and … the active metabolite of irinotecan, a topoisomerase I inhibitor … in the treatment of lung cancers, and a clinical … novel therapeutic approach in lung cancer. Lung Cancer. 2022;163:96– …
-
U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer
20 Dec 2024 19:17 GMT
… with cetuximab arm compared to irinotecan with cetuximab or FOLFIRI with … with cetuximab arm compared to irinotecan with cetuximab or FOLFIRI with … , and thoracic cancers, which includes lung cancer. Driven by science, we are …
-
Real-World Outcomes with Lurbinectedin in Second Line and Beyond for Extensive Stage Small Cell Lung Cancer in Korea
30 Oct 2024 08:51 GMT
… lung cancer (SCLC) accounts for approximately 10– 15% of all lung cancers … confirmed small cell lung cancer (SCLC) who … line chemotherapy regimens (topotecan, irinotecan + platinum (IP), and … stage small cell lung cancer. Clin Lung Cancer. 2023;24( …
-
Jazz's almost-withdrawn lung cancer drug Zepzelca extends life on top of Roche's Tecentriq
15 Oct 2024 19:25 GMT
… in extensive-stage small cell lung cancer (ES-SCLC).
Zepzelca, used in … /m2 in combination with irinotecan, versus physician’s choice of …
-
Goals of Therapy and Considerations for Treatment Sequencing in Extensive Stage Small Cell Lung Cancer
11 Oct 2024 17:15 GMT
… of extensive stage small cell lung cancer (ES-SCLC) that progress within … as tarlatamab, lurbinectedin, topotecan, and irinotecan should be considered, alongside the …
-
Pfizer’s BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically Meaningful Response in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
14 Sep 2024 08:50 GMT
… mutant metastatic non-small cell lung cancer (NSCLC). After an … approximately 80-85% of lung cancers,2 with BRAF V600E … with cetuximab compared to irinotecan with cetuximab or FOLFIRI … American Lung Association. BRAF and lung cancer. Available at: https:…
-
Unraveling the Mechanism of Curculiginis Rhizoma in Suppressing Cisplatin Resistance in Non-Small Cell Lung Cancer: An Experimental Study
12 Jun 2024 06:58 GMT
… and aggressive subtype of lung cancer, characterized by high malignancy … al. Taxane-platin-resistant lung cancers co-develop hypersensitivity to … chemotherapy resistance of lung cancer and their potential … ErbB2 modulates gemcitabine and irinotecan/SN-38 …
About
© 1995-2024